Skip to main content
Equibles
QUCY logo

QUCY · Quantum Cyber N.V.

Track QUCY — free

Use QUCY with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.56 +0.08 (+5.42%) At close · Sep 2
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“The Company has incurred recurring losses from operations and does not yet have an established source of revenues sufficient to cover its operating costs. These conditions raise substantial doubt about the Company's ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. Management evaluated conditions and events that raise substantial doubt and the Company's plans to mitigate those conditions over the one-year look-forward period from the date these consolidated financial statements are issued.”
View the 10-Q filed Aug 14, 2026
Market Cap
$124.42M
Shares
84.07M

QUCY metrics

47 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.48
Market cap
$124.42M

Price action

19 metrics
Price change (1W)
+8.8%
Price change (30D)
+17.5%
Price change (3M)
-39.6%
Price change (6M)
+77.0%
Price change (YTD)
+32.1%
Price change (1Y)
-11.9%
Trailing year
Price change (5Y)
—
52-week high
$3.56
52-week low
$0.32
Change from 52-week high
-58.4%
Change from 52-week low
+358.2%
Annualized volatility
355.6%
Beta
3.6
RSI (14D)
55.0
Price vs SMA 50
+9.8%
Price vs SMA 200
+24.2%
Avg volume (3M)
3.01M
Relative volume
0.5
Average dollar volume
$5.39M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
84.07M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
188.5×
reciprocal yield 0.5%
P / book
6.1
reciprocal yield 16.4%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
72.6%
Operating margin
-3,005.0%
Trailing 12 months
Net margin
-3,018.3%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$2.59

Growth

11 metrics
Revenue growth YoY
+140.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$659,935
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+308.5%
Year over year · more shares
Revenue CAGR (3Y)
+0.5%
Revenue CAGR (5Y)
+1.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-2,526.6%
Return on assets
-304.3%
Debt / equity
—
Current ratio
5.6
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$13.40M
Total assets
$23.37M
Total debt
$956,902

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
18
13F filer change QoQ
0
Institutional ownership
0.3%

Short interest

3 metrics
Short interest
3.1%
Latest settlement · 2.8 days to cover
Days to cover
2.8d
Short-squeeze score
54 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1874252 CUSIP N5436L119 13F (30d) 13 filings 13 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)